van Roeyen C - Search Results

1

Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis.

Niederacher D, Picard F, van Roeyen C, An HX, Bender HG, Beckmann MW. Niederacher D, et al. Among authors: van roeyen c. Genes Chromosomes Cancer. 1997 Mar;18(3):181-92. doi: 10.1002/(sici)1098-2264(199703)18:3<181::aid-gcc5>3.0.co;2-y. Genes Chromosomes Cancer. 1997. PMID: 9071571

2

Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer.

Beckmann MW, Picard F, An HX, van Roeyen CR, Dominik SI, Mosny DS, Schnürch HG, Bender HG, Niederacher D. Beckmann MW, et al. Among authors: van roeyen cr. Br J Cancer. 1996 May;73(10):1220-6. doi: 10.1038/bjc.1996.234. Br J Cancer. 1996. PMID: 8630282 Free PMC article.

3

Detection of sequential genetic alterations relevant for breast cancer development.

Niederacher D, Schnürch HG, An HX, Ellenberger I, Dall P, van Roeyen CR, Küppers V, Beckmann MW. Niederacher D, et al. Among authors: van roeyen cr. Eur J Cancer Prev. 1996 Dec;5(6):497-503. Eur J Cancer Prev. 1996. PMID: 9061283

4

ERBB2 gene amplification detected by fluorescent differential polymerase chain reaction in paraffin-embedded breast carcinoma tissues.

An HX, Niederacher D, Beckmann MW, Göhring UJ, Scharl A, Picard F, van Roeyen C, Schnürch HG, Bender HG. An HX, et al. Among authors: van roeyen c. Int J Cancer. 1995 Oct 20;64(5):291-7. doi: 10.1002/ijc.2910640502. Int J Cancer. 1995. PMID: 7591299

5

Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer.

An HX, Niederacher D, Picard F, van Roeyen C, Bender HG, Beckmann MW. An HX, et al. Among authors: van roeyen c. Genes Chromosomes Cancer. 1996 Sep;17(1):14-20. doi: 10.1002/(SICI)1098-2264(199609)17:1<14::AID-GCC3>3.0.CO;2-5. Genes Chromosomes Cancer. 1996. PMID: 8889502

6

P53 accumulation in precursor lesions and early stages of bladder cancer.

Schmitz-Dräger BJ, van Roeyen CR, Grimm MO, Gerharz CD, Decken K, Schulz WA, Bültel H, Makri D, Ebert T, Ackermann R. Schmitz-Dräger BJ, et al. Among authors: van roeyen cr. World J Urol. 1994;12(2):79-83. doi: 10.1007/BF00184241. World J Urol. 1994. PMID: 8087143

7

Predictive value of molecular alterations for the prognosis of urothelial carcinoma.

Schulz WA, Jankevicius F, Gerharz CD, Kushima M, van Roeyen C, Bültel H, Göbell P, Schmitz-Dräger BJ. Schulz WA, et al. Among authors: van roeyen c. Cancer Detect Prev. 1998;22(5):422-9. doi: 10.1046/j.1525-1500.1998.00048.x. Cancer Detect Prev. 1998. PMID: 9727623

8

c-myc in bladder cancer. Clinical findings and analysis of mechanism.

Schmitz-Dräger BJ, Schulz WA, Jürgens B, Gerharz CD, van Roeyen CR, Bültel H, Ebert T, Ackermann R. Schmitz-Dräger BJ, et al. Among authors: van roeyen cr. Urol Res. 1997;25 Suppl 1:S45-9. doi: 10.1007/BF00942047. Urol Res. 1997. PMID: 9079756

9

Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice.

Heller-Stilb B, van Roeyen C, Rascher K, Hartwig HG, Huth A, Seeliger MW, Warskulat U, Häussinger D. Heller-Stilb B, et al. Among authors: van roeyen c. FASEB J. 2002 Feb;16(2):231-3. doi: 10.1096/fj.01-0691fje. Epub 2001 Dec 28. FASEB J. 2002. PMID: 11772953

10

Biological responses to PDGF-BB versus PDGF-DD in human mesangial cells.

van Roeyen CR, Ostendorf T, Denecke B, Bokemeyer D, Behrmann I, Strutz F, Lichenstein HS, LaRochelle WJ, Pena CE, Chaudhuri A, Floege J. van Roeyen CR, et al. Kidney Int. 2006 Apr;69(8):1393-402. doi: 10.1038/sj.ki.5000332. Kidney Int. 2006. PMID: 16557224 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters